Cellcolabs

High-Quality Mesenchymal Stromal Cells

Scaling up Production to Reduce the Price.

Advanced stem cell treatments have the potential to transform health care as we know it. Despite this, there is a global shortage of stem cells produced in compliance with Good Manufacturing Practice (GMP) standards. To bridge this gap, Cellcolabs was established in 2021, aiming to meet the demand for high-quality, GMP-compliant stem cells in the healthcare sector.

CONTACT

Address: 
Panorama Tower 2. Apt 303,
Dubai
United Arab Emirates

Website: www.cellcolabs.com

Contact: Peter Ekstedt, CEO

Email: peter@ekstedt.biz
Phone: 0551526732